FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087464759> ?p ?o ?g. }

• W3087464759 abstract "Abstract Triple-negative breast cancer (TNBC), defined as loss of estrogen, progesterone, and Her2 receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor survival rate. Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine aberrantly expressed in many solid tumors and known to promote tumor progression and metastasis. However, its role in TNBC progression and metastasis is unexplored. Here we have shown that in TNBC patients, MIF expression was significantly enriched in the tumor compared to adjacent normal tissue. Using publically available patient datasets, we showed that MIF overexpression correlates with worse survival in TNBC compared to other hormonal status. Orthotopic implantation of TNBC cells into MIF knockout mice showed reduced tumor growth compared to wild-type mice. In addition, we have shown that MIF downregulation inhibits TNBC growth and progression in a syngeneic mouse model. We further showed that CPSI-1306, a small-molecule MIF inhibitor, inhibits the growth of TNBC cells in vitro. Mechanistic studies revealed that CPSI-1306 induces intrinsic apoptosis by alteration in mitochondrial membrane potential, cytochrome c (Cyt c ) release, and activation of different caspases. In addition, CPSI-1306 inhibits the activation of cell survival and proliferation-related molecules. CPSI-1306 treatment also reduced the tumor growth and metastasis in orthotopic mouse models of mammary carcinoma. CPSI-1306 treatment of tumor-bearing mice significantly inhibited TNBC growth and pulmonary metastasis in a dose-dependent manner. Histological analysis of xenograft tumors revealed a higher number of apoptotic cells in CPSI-1306-treated tumors compared to vehicle controls. Our studies, for the first time, show that MIF overexpression in TNBC enhances growth and metastasis. Taken together, our results indicate that using small molecular weight MIF inhibitors could be a promising strategy to inhibit TNBC progression and metastasis." @default.
• W3087464759 created "2020-09-25" @default.
• W3087464759 creator A5022709344 @default.
• W3087464759 creator A5027775199 @default.
• W3087464759 creator A5029762163 @default.
• W3087464759 creator A5035610335 @default.
• W3087464759 creator A5041668127 @default.
• W3087464759 creator A5067698508 @default.
• W3087464759 creator A5069418264 @default.
• W3087464759 creator A5070076002 @default.
• W3087464759 creator A5082671116 @default.
• W3087464759 creator A5090814314 @default.
• W3087464759 date "2020-09-17" @default.
• W3087464759 modified "2023-10-08" @default.
• W3087464759 title "Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer" @default.
• W3087464759 cites W1854253459 @default.
• W3087464759 cites W1893818399 @default.
• W3087464759 cites W1969690844 @default.
• W3087464759 cites W19803778 @default.
• W3087464759 cites W1981376684 @default.
• W3087464759 cites W1984567166 @default.
• W3087464759 cites W1986837253 @default.
• W3087464759 cites W1992832780 @default.
• W3087464759 cites W1996177324 @default.
• W3087464759 cites W1998734250 @default.
• W3087464759 cites W2000482482 @default.
• W3087464759 cites W2005659570 @default.
• W3087464759 cites W2005895632 @default.
• W3087464759 cites W2032894034 @default.
• W3087464759 cites W2042986670 @default.
• W3087464759 cites W2043310375 @default.
• W3087464759 cites W2049679215 @default.
• W3087464759 cites W2061354386 @default.
• W3087464759 cites W2068524531 @default.
• W3087464759 cites W2087441379 @default.
• W3087464759 cites W2088270875 @default.
• W3087464759 cites W2091143198 @default.
• W3087464759 cites W2096283457 @default.
• W3087464759 cites W2104801060 @default.
• W3087464759 cites W2118758371 @default.
• W3087464759 cites W2119975486 @default.
• W3087464759 cites W2131994307 @default.
• W3087464759 cites W2135757311 @default.
• W3087464759 cites W2140287290 @default.
• W3087464759 cites W2146088970 @default.
• W3087464759 cites W2153213901 @default.
• W3087464759 cites W2165892241 @default.
• W3087464759 cites W2517270366 @default.
• W3087464759 cites W2522708935 @default.
• W3087464759 cites W2538555622 @default.
• W3087464759 cites W2588560311 @default.
• W3087464759 cites W2790757017 @default.
• W3087464759 cites W2806725873 @default.
• W3087464759 cites W2807589914 @default.
• W3087464759 cites W2898994124 @default.
• W3087464759 cites W2938196301 @default.
• W3087464759 cites W2960943033 @default.
• W3087464759 cites W2981079812 @default.
• W3087464759 cites W2989952835 @default.
• W3087464759 cites W3000694076 @default.
• W3087464759 cites W3004118171 @default.
• W3087464759 cites W3005312454 @default.
• W3087464759 cites W3036960489 @default.
• W3087464759 doi "https://doi.org/10.1038/s41419-020-02992-y" @default.
• W3087464759 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7498597" @default.
• W3087464759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32943608" @default.
• W3087464759 hasPublicationYear "2020" @default.
• W3087464759 type Work @default.
• W3087464759 sameAs 3087464759 @default.
• W3087464759 citedByCount "32" @default.
• W3087464759 countsByYear W30874647592021 @default.
• W3087464759 countsByYear W30874647592022 @default.
• W3087464759 countsByYear W30874647592023 @default.
• W3087464759 crossrefType "journal-article" @default.
• W3087464759 hasAuthorship W3087464759A5022709344 @default.
• W3087464759 hasAuthorship W3087464759A5027775199 @default.
• W3087464759 hasAuthorship W3087464759A5029762163 @default.
• W3087464759 hasAuthorship W3087464759A5035610335 @default.
• W3087464759 hasAuthorship W3087464759A5041668127 @default.
• W3087464759 hasAuthorship W3087464759A5067698508 @default.
• W3087464759 hasAuthorship W3087464759A5069418264 @default.
• W3087464759 hasAuthorship W3087464759A5070076002 @default.
• W3087464759 hasAuthorship W3087464759A5082671116 @default.
• W3087464759 hasAuthorship W3087464759A5090814314 @default.
• W3087464759 hasBestOaLocation W30874647591 @default.
• W3087464759 hasConcept C104177226 @default.
• W3087464759 hasConcept C121608353 @default.
• W3087464759 hasConcept C126322002 @default.
• W3087464759 hasConcept C190283241 @default.
• W3087464759 hasConcept C2776187077 @default.
• W3087464759 hasConcept C2778287671 @default.
• W3087464759 hasConcept C2778690821 @default.
• W3087464759 hasConcept C2779013556 @default.
• W3087464759 hasConcept C2779256057 @default.
• W3087464759 hasConcept C2780110267 @default.
• W3087464759 hasConcept C502942594 @default.
• W3087464759 hasConcept C530470458 @default.
• W3087464759 hasConcept C55493867 @default.
• W3087464759 hasConcept C71924100 @default.
• W3087464759 hasConcept C86803240 @default.

• next